Electrophysiologic analyses during chronic application of opioids to organotypic explants of fetal mouse spinal cord with attached dorsal root ganglia (DRGs) demonstrate that isolated mammalian CNS tissues can develop marked tolerance after several days' exposure in vitro. The marked decreases in opioid sensitivity of DRG-evoked dorsal-horn network responses observed during chronic opioid exposure of cord-DRG explants will be closely coordinated with biochemical assays to test the hypothesis that the physiologic expression of tolerance may be mediated by significant enhancement of adenylate cyclase activity and cyclic AMP levels. These studies will be correlated with analyses of the acute tolerance-like state produced by brief exposure of cord-DRG explants to forskolin or other agents that elicit a rise in intracellular cyclic AMP. In order to clarify other factors that may regulate opioid tolerance, correlative physiologic and biochemical analyses will be made after physicochemical alterations of the culture environment during chronic opioid exposure, e.g. addition of specific metabolic or pharmacologic blocking agents. Extracellular recordings of dorsal-horn responses during chronic exposure to opioids--or acute exposure to forskolin and cyclic AMP analogs--will be correlated with intracellular recordings from the DRG and cord neurons. These analyses will clarify pre-and post-synaptic alterations in dorsal-horn network functions that may occur in tolerant explants. Factors leading to the marked upregulation of opiate receptor levels that occurs in mature cord-DRG explants after chronic exposure to naloxone will be analyzed, using specific metabolic/pharmacologic blocking agents and autoradiography. Electrophysiologic analyses, binding assays and autoradiography will be coordinated to determine if developmental redistribution, disappearance, or functional inactivation of opiate receptors may account for the spinal cord-regulated decrease in the fraction of opioid-sensitive DRG neuron perikarya observed in DRG-cord vs. isolated DRG explants. Development of opioid dorsal-horn networks and their DRG inputs will also be studied during chronic exposure of embryonic tissues to opioid agonists or antagonists at early stages in vitro. The proposed studies should provide valuable insights into mechanisms of tolerance and plasticity in opioid systems of the CNS and problems in maternal narcotic addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002031-09
Application #
3207087
Study Section
(DABB)
Project Start
1978-07-01
Project End
1989-02-28
Budget Start
1988-03-01
Budget End
1989-02-28
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Shen, K F; Crain, S M (1994) Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells. J Neurosci 14:5570-9
Shen, K F; Crain, S M (1994) Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Res 636:286-97
Cruciani, R A; Dvorkin, B; Klinger, H P et al. (1994) Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res 667:229-37
Cruciani, R A; Dvorkin, B; Morris, S A et al. (1993) Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci U S A 90:3019-23
Fan, S F; Shen, K F; Crain, S M (1993) mu and delta opioid agonists at low concentrations decrease voltage-dependent K+ currents in F11 neuroblastoma x DRG neuron hybrid cells via cholera toxin-sensitive receptors. Brain Res 605:214-20
Crain, S M; Shen, K F (1992) After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J Pharmacol Exp Ther 260:182-6
Shen, K F; Crain, S M (1992) Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance. Brain Res 597:74-83
Crain, S M; Shen, K F (1992) After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res 575:13-24
Fan, S F; Shen, K F; Scheideler, M A et al. (1992) F11 neuroblastoma x DRG neuron hybrid cells express inhibitory mu- and delta-opioid receptors which increase voltage-dependent K+ currents upon activation. Brain Res 590:329-33
Terwilliger, R Z; Beitner-Johnson, D; Sevarino, K A et al. (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-10

Showing the most recent 10 out of 28 publications